Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bambauer, K. Z.
Right arrow Articles by McLaughlin, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bambauer, K. Z.
Right arrow Articles by McLaughlin, T. J.
Related Collections
Right arrow Other Cardiovascular Medicine
Right arrow Therapeutic Interventions
Psychosomatic Medicine 67:539-545 (2005)
© 2005 American Psychosomatic Society


ORIGINAL ARTICLES

The Effect of a Telephone Counseling Intervention on Self-Rated Health of Cardiac Patients

Kara Zivin Bambauer, PhD, Onesky Aupont, MD, PhD, Peter H. Stone, MD, Steven E. Locke, MD, Mariquita G. Mullan, PhD, Jane Colagiovanni and Thomas J. McLaughlin, ScD

From Harvard Medical School (K.Z.B., O.A., P.H.S., S.E.L., T.J.M.), Harvard Pilgrim Health Care (K.Z.B., O.A., M.G.M., J.C., T.J.M.), Beth Israel Deaconess Medical Center (S.E.L.), and Brigham and Women’s Hospital (P.H.S.), Boston, Massachusetts.

Address correspondence and reprint requests to Thomas J. McLaughlin, ScD, Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, 133 Brookline Avenue, 6th Floor, Boston, MA 02215. E-mail: thomas_mclaughlin{at}hms.harvard.edu


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Objective: The objective of this study was to evaluate the effectiveness of a telephone-based intervention on psychological distress among patients with cardiac illness.

Methods: We recruited hospitalized patients surviving an acute coronary syndrome with scores on the Hospital and Anxiety Depression Scale (HADS) indicating mild to severe depression and/or anxiety at 1 month postdischarge. Recruited patients were randomized into either an intervention or control group. Intervention patients received up to six 30-minute telephone-counseling sessions focused on identifying cardiac-related fears. Control patients received usual care. For both groups, we collected patients’ responses to the HADS and to the Global Improvement (CGI-I) subscale of the Clinical Global Impressions (CGI) Scale at baseline and at 2, 3, and 6 months postbaseline using Interactive Voice Recognition (IVR) technologies. We used mixed-effects analysis to estimate patients’ changes in CGI-I measures over the three time points of data collection postbaseline.

Results: We enrolled 100 patients, and complete CGI-I measures were collected for 79 study patients. The mean age was 60 years (standard deviation = 10), and 67% of the patients were male. A mixed-effects analysis confirmed that patients in the intervention group had significantly greater improvements in self-rated health (SRH) between baseline and month 3 than the control group (p = .01). Between month 3 and month 6, no significant differences in SRH improvements were observed between the control and intervention groups.

Conclusions: Study patients reported greater SRH improvement resulting from the telephone-based intervention compared with control subjects. Future research should include additional outcome measures to determine the effect of changes in SRH on patients with comorbid physical and emotional disorders.

Key Words: adjustment to chronic disease • cardiac disease • psychological distress • randomized controlled trial • self-rated health • telephone counseling

Abbreviations: ACS = acute coronary syndrome; ADL = activities of daily living; CAD = coronary artery disease; CGI = Clinical Global Impressions Scale; CGI-I = Global Improvement subscale of the Clinical Global Impressions (CGI) Scale; ENRICHD = Enhancing Recovery in Heart Disease Patients trial; HADS = Hospital and Anxiety Depression Scale; HTS = Healthcare Technology Systems; ICD-9 = International Classification of Diseases, Ninth Edition; IRB = Institutional Review Boards; IVR = interactive voice recognition; MI = myocardial infarction; SADHART = the Sertraline Antidepressant Heart Attack Randomized Trial; SRH = self-rated health.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Self-ratedhealth (SRH) has been shown repeatedly to be an important predictor of morbidity and mortality (1–7) and a major component of quality of life (7–11). Both physical and mental diseases can influence SRH (7). In addition to the impact that mental and physical disorders separately have on SRH, comorbid physical and mental diseases cause increased morbidity and mortality compared with either disease alone (12,13). For example, patients who struggle with both depression and coronary artery disease (CAD) have worse health prognosis and outcomes than patients with either depression or CAD alone (14–18). Major depression, minor depressive disorders, and anxiety are all independent risk factors for mortality and diminished quality of life in cardiac patients (19–32). After myocardial infarction (MI), mood disorders appear to slow recovery, and have a negative impact on social functioning and capacity to perform activities of daily living (ADL) (17,33). Depressive disorders are associated with increased costs, in part as a result of higher rates of hospital readmission and inpatient procedures such as angiography and catheterization (17,27,30,34–36).

Both pharmacological and psychosocial treatments for mood disorders among patients with CAD can improve patients’ prognosis and quality of life (22,34,37,38). Several studies also have demonstrated that psychosocial treatments focusing on social support (30,39,40), self-efficacy (41), affect (42), and coping style (30,43) appear to be components of an effective intervention for reducing depressive symptoms in cardiac patients. Although research results have not agreed on a mortality-reducing effect of depression treatment among cardiac patients, treatments to alleviate depression in patients with an acute coronary syndrome (ACS) may improve SRH and quality of life (44). Therefore, a key remaining question is whether psychosocial treatment for mental distress among patients with CAD might improve self-rated health.

The present study used a telephone-based counseling intervention to treat psychological distress among patients recently hospitalized for ACS. In contrast to traditional psychotherapy, this intervention focused not on underlying psychopathology, but on the patients’ adjustment to the effects of chronic illness (45). The goal is to help patients adjust successfully to illness by strengthening existing coping mechanisms and mobilizing resources (45). This longitudinal study examined whether a telephone counseling intervention improved patient SRH.

Objective
This study aimed to determine if the intervention led to SRH improvement among distressed patients with heart disease. We hypothesized that patients who received the intervention would experience greater SRH improvements over time than control patients.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Overall Design
This study was a prospective, two-arm, randomized, controlled trial of telephone counseling versus usual care in the treatment of psychologically distressed patients surviving recent ACS. We identified a cohort of patients hospitalized for ACS at a Boston-area medical school and teaching hospital. Hospitalized patients were targeted who met the inclusion and exclusion criteria described subsequently. Eligible, consenting patients were randomized to usual care or experimental treatment consisting of up to six 30-minute telephone counseling sessions conducted at weekly intervals. To measure study outcomes, intervention and control patients were asked to complete four interactive voice recognition (IVR) assessment questionnaires at baseline and at 2, 3, and 6 months postbaseline to assess the impact of the intervention on SRH.

Setting and Sources of Data
A major teaching hospital in Boston, Massachusetts, with large case-mixes of patient populations served as the study site. After approval by the Institutional Review Boards (IRBs) was obtained, patients who met specific inclusion criteria were recruited beginning in the fall of 2001 and ending in the summer of 2003.

Inclusion Criteria
Hospitalized patients were identified by medical chart review conducted by a cardiac research nurse to determine the presence of inclusion and exclusion criteria. Patients aged 35 years or older who had a primary diagnosis of ACS defined as unstable angina pectoris or acute myocardial infarction met the inclusion criteria for the study. Patients were excluded who had a history of substance abuse, mental health care, or antidepressant use in the 3 months preceding the index hospitalization.

Patients meeting these criteria were asked if they would be willing to be contacted once they returned home from the hospital. The study coordinator contacted consenting patients by telephone 1 to 2 weeks postdischarge and screened them over the telephone for depression and anxiety symptoms using the Hospital Anxiety and Depression Scale (HADS) (46). Patients with HADS scores indicating depression and/or anxiety symptoms were asked to participate in the study. During this screening telephone call, patients were randomized to one of the two study treatment arms.

Cohort Identification, Randomization, and Intervention
Eligible patients were randomized to either the intervention or usual care (control) group. The principal investigator of the study (T.J.M.) determined that patients would be randomized to either intervention or control status by using a coin flip. The study coordinator (J.C.) conducted the coin flip and assigned patients to a treatment arm when she contacted study participants by telephone and enrolled consenting participants. Participants could not be blinded to treatment assignment because patients in the intervention arm received telephone counseling, whereas the usual care patients did not. Sample size was determined based on power calculations to detect a difference of two units in HADS depression scores and indicated a required total sample of 68 patients. However, we enrolled 100 patients to control for possible loss to follow up at baseline. Enrollment occurred between September 2001 and August 2003.

Control Group
Control patients received a short booklet on coping with chronic illness and were instructed to contact their primary care physician if they experienced any warning signs of more significant depression. They were advised to continue to follow up with their primary care and specialist physicians as they normally would for ongoing care.

Intervention Group
Patients in the intervention group received up to a total of six telephone counseling sessions over a period of 8 weeks. The intervention addressed eight specific issues or fears, including loss of control, loss of self-image, dependency, stigma, abandonment, anger, isolation, and fear of death (45). All sessions were 30 minutes long and were administered by doctoral-level clinicians (a psychiatrist, a clinical psychologist, and/or an internist). Most patients were expected to complete six sessions, but they were allowed to participate in as few as three sessions, depending on the therapist’s assurance that all eight issues set forth during the counseling process were reviewed and that the treatment goal was reached, signaling the completion of treatment. Patients were also able to initiate telephone contact with the counselor and were provided with an emergency telephone number. A record of the sessions was kept to indicate issues reviewed, as well as to serve as a reference for the counselor as the patient progressed through the sessions. It is important to note that this intervention is not the same as traditional psychotherapy; rather, it helps patients identify and build their own capacity to manage the personal effects of chronic illness. It is goal-oriented, time-limited, and issue-focused in contrast to other forms of psychosocial treatment.

Measures
Data on study patients retrieved from the hospital medical records by the research nurse and study coordinator included age, gender, race, history of ischemic cardiac disease, dates of hospital admission and discharge, length of hospital stay, cardiac discharge diagnosis, cardiac procedure descriptors, and depression diagnosis (as assessed using the Primary Care Evaluation of Mental Disorders (47)). A data management and research organization with extensive experience in management of behavioral health data collected patients’ baseline scores and all follow-up data at months 2, 3, and 6. Patients in both treatment groups were asked to provide their responses to the HADS and the Global Improvement (CGI-I) (discussed subsequently) administered over the telephone using computer-assisted IVR technology by pressing telephone keys indicating their responses to each measure’s questions.

Indicator of Psychological Distress
Symptoms of depression and anxiety were assessed in study subjects using the HADS. Each HADS subscale contains 14 items rated on four-point Likert scales using seven questions to assess anxiety and seven questions to assess depression (46). Each subscale is scored on a scale from 0 to 21, in which patients with a score of 0 to 4 are considered to be "normal," 4 to 7 are considered to have "subclinical" depression, 8 to 10 have mild depression, 11 to 14 have moderate depression, and 15 to 21 have severe depression (46). In this study, patients were deemed eligible to participate if they had a score of seven or higher on either the depression or the anxiety subscale on the initial HADS screen conducted postdischarge. The criteria for choosing a cutoff on the HADS depression subscale or anxiety subscale were purposely lenient to be sure that all distressed patients were eligible to participate in the study.

Health Outcome Measurement
The primary outcome measure in this study was the CGI-I subscale of the Clinical Global Impressions (CGI) Scale (48), a standardized assessment tool that is widely used in clinical psychopharmacology trials as an outcome measure of SRH (49,50). The CGI-I is scored from one to seven, in which a score of one indicates a patient feels "very much better" than baseline and a score of seven indicates a patient feels "very much worse" than baseline. In this case, patients are asked to compare how their health is at the present compared with when they first began participating in the study (baseline). A score of four means that a patient feels "unchanged" from baseline and is also used in this article as the referent score to which changes are compared. Therefore, the CGI-I is actually a change score that assesses the patient’s improvement or worsening from baseline (50).

Statistical Analysis
Descriptive analyses on baseline demographic and other patient characteristics (e.g., age and gender) were performed. t tests and chi-squared tests were used to validate the randomization process and to test for comparability between the intervention and control arms.

Differences in CGI-I measures between the control and intervention groups were assessed at months 2, 3, and 6 using SAS PROC MIXED to model the repeated measures over the three time periods in the two treatment arms. Patient-level slopes and intercepts were modeled as random effects. A random-effects covariance structure using intercepts and slopes was used (51,52). This model controls for the correlated outcome measures (i.e., within-person correlation of responses) and allows each person to contribute different numbers of follow-up responses.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Figure 1 presents the study cohort as derived from an original potential group of 706 patients. Patients were enrolled into the study beginning in September 2001 and ending in July 2003. Each participant was followed for 6 months postenrollment; therefore, data collection was completed in January 2004. Most patients not in the study cohort were ineligible to participate in the study as a result of failure to meet the entry criteria of a HADS depression or anxiety subscale screening score of seven or higher. After exclusions and prebaseline dropouts, 79 patients remained who had symptoms of depression and/or anxiety when screened. Among these 79 study participants, 34 were control patients and 45 were intervention patients.



View larger version (35K):
[in this window]
[in a new window]
 
Figure 1. Study cohort as derived from the original cohort.

 

Table 1 presents baseline characteristics of study subjects by treatment status. The mean age was 60 (SD = 10), and 67% of the patients were male. Baseline patient characteristics such as age, cardiac condition, gender, length of stay, major depression diagnosis, and race were balanced between the two study groups. (It is important to note that patients were included in this study based on HADS scores, not based on the presence of a major depression diagnosis.) Therefore, these variables dropped out of the analysis. No baseline CGI-I score is available because CGI-I is a change score. However, Figure 2 highlights the changes in CGI-I score from an assumed CGI-I baseline score of 4.0. A regression line was used to illustrate the changes in CGI-I score at each follow-up time between month 2 and month 6.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Baseline Characteristics of 79 Study Participants

 


View larger version (16K):
[in this window]
[in a new window]
 
Figure 2. Predicted mean Global Improvement subscale of the Clinical Global Impressions Scale over time.

 

The mixed-effects analysis (shown in Table 2 and Fig. 2) confirmed that patients in the intervention group had significantly better improvements in SRH over time (p = .01) relative to the control group. The average number of counseling sessions administered was four (SD = 2). There was no dose–response relationship between number of telephone sessions and SRH outcome. There was no significant difference in outcome based on type of clinician administering counseling.


View this table:
[in this window]
[in a new window]
 
TABLE 2. Predictors of CGI-I Levels Over Time

 

Table 3 outlines changes in mean CGI-I scores in the two groups over time. Mean CGI-I scores at month 2 indicate that patients in the control group felt "unchanged" to "a little better" (with a mean score of 3.33), whereas intervention patients felt "a little better" to "much better" (with a mean score of 2.64, p < .01). This effect remains significant at month 3, when the mean intervention score is 3.25 and the mean control score is 2.44 (p = .01). Table 4 shows the proportion of "CGI-I responders" over time, indicating whether patients are feeling "much better" or "very much better" as compared with baseline (which corresponds to a CGI-I score of two or less). Patients in the intervention group had significantly more CGI-I responders by month 2 (54%) as compared with the control patients (27%, p = .02). Although by month 6 there were no significant differences in SRH improvement reported by the two study arms, intervention patients still reported higher absolute SRH improvements than controls.


View this table:
[in this window]
[in a new window]
 
TABLE 3. Changes in CGI-I Scores Over Time

 

View this table:
[in this window]
[in a new window]
 
TABLE 4. Proportion of CGI-I Responders Over Time

 

Although not a focus of this paper, patient HADS scores for both the depression and anxiety subscales decreased over time, with significantly greater decreases in the intervention patients compared with control patients.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
This study provides additional support for the use of telephone-based counseling as a treatment tool for mental disorders such as anxiety and depression. We found that patients in the telephone-based intervention group reported a greater level of SRH improvement. Patients in the intervention group had both a statistically and clinically significant improvement in CGI-I compared with the control group by 2 months after baseline. Clinical significance for measures of quality of life such as the CGI has been conservatively estimated at 0.5 SDs, or here, approximately 0.5 CGI-I points at each time point (53). The benefits realized at 2 months postbaseline persisted over the study period, although SRH in control patients slowly improved over time as well. Given what we know about the relationship between SRH and health outcomes, we might speculate that patients who experienced SRH improvement also would have improved health outcomes (i.e., decreased morbidity and mortality associated with heart disease) as well.

Recent clinical trials of cardiac patients such as the the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) and the Enhancing Recovery in Heart Disease Patients (ENRICHD) trials showed that depression treatment is effective in cardiac patients (49,54). Although the ENRICHD study did not find that treatment of depression in cardiac patients decreased cardiac-related mortality, potential design flaws in this study may have limited its ability to detect a beneficial effect of depression treatment on mortality. Other evidence suggests that "psychosocial interventions may be associated with benefits to patients with CAD over and above those achieved by medication and exercise—both in terms of improved quality of life as well as reduced mortality" (43).

Two recently published reports of telephone-based depression medication management programs demonstrated the effectiveness of telemedicine modalities of care in improving patient outcomes (55,56). The first of these studies, by Hunkeler et al (55), showed that telephone calls made by primary care nurses to depressed patients being treated with antidepressants in a primary care practice decreased depressive symptoms and increased patient functioning and satisfaction with care relative to patients who did not receive such calls. This study also demonstrated that this successful intervention did not require staffing changes and was thus feasible in a primary care population.

The second study, by Simon et al (56) demonstrated that telephonic antidepressant management in primary care populations improves depression outcomes. It also suggested that benefits of telephone treatment strategies are cost-effective and efficient because they decrease travel time for patients, increase access to treatment for patients with restricted mobility, and cost less for patients than office visits.

The present study extends the findings from these studies by demonstrating that a telephone-based psychosocial intervention can also be a successful strategy to improve patient SRH and level of mental distress (rather than telephone management that focuses principally on managing antidepressant use). Linden et al documented that psychosocial interventions decrease psychological distress, heart rate, cholesterol levels, and systolic blood pressure. Their work validated the benefits of psychosocial interventions in cardiac patients (43). We argue that telephone counseling interventions promise to be a more efficient, effective, and financially feasible means to decrease symptoms of mood disorders and improve the functioning of chronically ill patients than traditional, in-person, in-office counseling.

Furthermore, despite its importance as a predictor of morbidity and mortality, SRH has typically been assessed only in cross-sectional studies (3,9,57,58). Thus, this study is unique because it was a randomized, controlled trial that examined changes in SRH over time among patients identified as experiencing psychological distress persisting a few weeks after hospital discharge for life-threatening acute coronary syndrome. The CGI-I was used in this study as a measure of SRH because often, one global question of SRH is a reliable and valid measure of health status (4–6,59,60). A single item may better reflect patient health status and potential mortality than underlying medical conditions and risk factors (61). This type of single measure is quick and easy to administer, and it is especially useful when other measures of health outcomes are lacking (59).

However, although this study demonstrated the benefits of the intervention for distressed patients with ACS, a few limitations should be noted. This study has a relatively small sample size. However, a highly statistically significant difference (p = .02) in SRH improvement was detected by 2 months postbaseline.

It is worth noting that control patients also continued to improve over time such that at 6 months postbaseline, no significant differences were observed in the two study groups. Several mechanisms could explain this finding. First, patients adjust to chronic illness over time. Second, the changes could be the result of regression to the mean (62). When patients were first assessed 1 month after hospital discharge for cardiac illness, their experience of SRH may have been much more negative than it would have been under normal circumstances. As patients’ health improved, their comparison of their SRH to when they first were hospitalized would, on average, tend toward improvement over time. Furthermore, the intervention patients experienced more rapid and lasting improvements in SRH such that by the end of the study (6 months postbaseline), control patients never reached the level of CGI-I improvement that intervention patients reached by month two (control patients reached an average CGI-I score of 3 by month six, whereas the intervention patients achieved an average CGI-I score of 2.64 by month two).

Another concern is the fact that we used only one of the three subparts of the CGI measure, the CGI-I subpart, which addresses patient perception of health improvement, without including its Severity of Illness and Efficacy Index subscales. However, as we discussed earlier, a single global measure of health status has been repeatedly shown to be a valid, reliable, and effective means of measuring patient morbidity, morality, and quality of life (1,2,4,8,9).

An additional concern is that we did not have access to patient clinical outcome data such as heart-related surgeries and procedures, medications, rehospitalizations, and so on. However, because baseline patient demographic characteristics and cardiac conditions were balanced in the two study groups, clinical outcomes should have also been balanced in the two intervention groups.

Finally, it is uncertain to what extent this study is generalizable to patients with other mental and physical disorders. Although this is a concern in any clinical trial, it is reassuring to note that the results from this study are comparable to those of other studies, suggesting that treatment of mental and physical health disorders can improve patient perception of health status.

Despite any limitations, it is clear that the intervention had a significant effect on patient SRH among distressed patients hospitalized for cardiac disease. Potential convenience for both patients and providers, as well as the effectiveness of the intervention for patients who experienced a cardiac-related hospitalization, indicate that this treatment might be an effective add-on to disease management programs.

We acknowledge Leslie Griffin, Michael Johnstone, Elaine Polishuk, Stephen Soumerai, and Katherine Swartz for helpful contributions to an earlier draft of this paper.


    NOTES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 

Received for publication September 21, 2004; revision received January 26, 2005.

DOI:10.1097/01.psy.0000171810.37958.61


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 

  1. Bailis DS, Segall A, Chipperfield JG. Two views of self-rated general health status. Soc Sci Med 2003;56:203–17.
  2. Fayers PM, Sprangers MA. Understanding self-rated health. Lancet 2002;359:187–8.[CrossRef][Medline]
  3. Han B. Depressive symptoms and self-rated health in community-dwelling older adults: a longitudinal study. J Am Geriatr Soc 2002;50:1549–56.[CrossRef][Medline]
  4. Idler EL, Benyamini Y. Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 1997;38:21–37.[CrossRef][Medline]
  5. Mackenbach JP, Simon JG, Looman CW, Joung IM. Self-assessed health and mortality: could psychosocial factors explain the association? Int J Epidemiol 2002;31:1162–8.[Abstract/Free Full Text]
  6. Manderbacka K, Kareholt I, Martikainen P, Lundberg O. The effect of point of reference on the association between self-rated health and mortality. Soc Sci Med 2003;56:1447–52.
  7. Molarius A, Janson S. Self-rated health, chronic diseases, and symptoms among middle-aged and elderly men and women. J Clin Epidemiol 2002;55:364–70.[CrossRef][Medline]
  8. Benyamini Y, Leventhal EA, Leventhal H. Elderly people’s ratings of the importance of health-related factors to their self-assessments of health. Soc Sci Med 2003;56:1661–7.
  9. Leinonen R, Heikkinen E, Jylha M. Self-rated health and self-assessed change in health in elderly men and women: a five-year longitudinal study. Soc Sci Med 1998;46:591–7.
  10. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001;63:221–30.[Abstract/Free Full Text]
  11. Rumsfeld JS, Magid DJ, Plomondon ME, Sales AE, Grunwald GK, Every NR, Spertus JA. History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J 2003;145:493–9.[CrossRef][Medline]
  12. Krantz DS, McCeney MK. Effects of psychological and social factors on organic disease: a critical assessment of research on coronary heart disease. Annu Rev Psychol 2002;53:341–69.[CrossRef][Medline]
  13. Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu Rev Psychol 2002;53:83–107.[CrossRef][Medline]
  14. Romanelli J, Fauerbach JA, Bush DE, Ziegelstein RC. The significance of depression in older patients after myocardial infarction. J Am Geriatr Soc 2002;50:817–22.[CrossRef][Medline]
  15. Appels A. Depression and coronary heart disease: observations and questions. J Psychosom Res 1997;43:443–52.[CrossRef][Medline]
  16. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192–217.[Abstract/Free Full Text]
  17. Clarke SP, Frasure-Smith N, Lesperance F, Bourassa MG. Psychosocial factors as predictors of functional status at 1 year in patients with left ventricular dysfunction. Res Nurs Health 2000;23:290–300.[CrossRef][Medline]
  18. Lesperance F, Frasure-Smith N, Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 1996;58:99–110.[Abstract/Free Full Text]
  19. Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, O’Connor CM, Siegler IC, Williams RB. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996;78:613–7.[CrossRef][Medline]
  20. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, Fauerbach JA. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001;88:337–41.[CrossRef][Medline]
  21. Carney RM, Blumenthal JA, Catellier D, Freedland KE, Berkman LF, Watkins LL, Czajkowski SM, Hayano J, Jaffe AS. Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol 2003;92:1277–81.[CrossRef][Medline]
  22. Cossette S, Frasure-Smith N, Lesperance F. Clinical implications of a reduction in psychological distress on cardiac prognosis in patients participating in a psychosocial intervention program. Psychosom Med 2001;63:257–66.[Abstract/Free Full Text]
  23. Crowe JM, Runions J, Ebbesen LS, Oldridge NB, Streiner DL. Anxiety and depression after acute myocardial infarction. Heart and Lung: Journal of Acute and Critical Care 1996;25:98–107.
  24. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993;270:1819–25.[Abstract]
  25. Frazier SK, Moser DK, O’Brien JL, Garvin BJ, An K, Macko M. Management of anxiety after acute myocardial infarction. Heart and Lung: Journal of Acute and Critical Care 2002;31:411–20.[CrossRef]
  26. Guck TP, Kavan MG, Elsasser GN, Barone EJ. Assessment and treatment of depression following myocardial infarction. Am Fam Physician 2001;64:641–8.[Medline]
  27. Januzzi JL Jr, Stern TA, Pasternak RC, DeSanctis RW. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 2000;160:1913–21.[Free Full Text]
  28. Lesperance F, Frasure-Smith N, Juneau M, Theroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000;160:1354–60.[Abstract/Free Full Text]
  29. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002;105:1049–53.[Abstract/Free Full Text]
  30. MacMahon KM, Lip GY. Psychological factors in heart failure: a review of the literature. Arch Intern Med 2002;162:509–16.[Abstract/Free Full Text]
  31. Nemeroff CB, Musselman DL, Evans DL. Depression and cardiac disease. Depress Anxiety 1998;8:71–9.
  32. Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, van Tilburg W. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001;58:221–7.[Abstract/Free Full Text]
  33. Burg MM, Abrams D. Depression in chronic medical illness: the case of coronary heart disease. J Clin Psychol 2001;57:1323–37.[CrossRef][Medline]
  34. Luutonen S, Holm H, Salminen JK, Risla A, Salokangas RK. Inadequate treatment of depression after myocardial infarction. Acta Psychiatr Scand 2002;106:434–9.[CrossRef][Medline]
  35. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, Blazing MA, Davenport C, Califf RM, Krishnan RR, O’Connor CM. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001;161:1849–56.[Abstract/Free Full Text]
  36. Lauzon C, Beck CA, Huynh T, Dion D, Racine N, Carignan S, Diodati JG, Charbonneau F, Dupuis R, Pilote L. Depression and prognosis following hospital admission because of acute myocardial infarction. Can Med Assoc J 2003;168:547–52.[Abstract/Free Full Text]
  37. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998;55:580–92.[Abstract/Free Full Text]
  38. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91:999–1005.[Abstract/Free Full Text]
  39. Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Talajic M, Bourassa MG. Social support, depression, and mortality during the first year after myocardial infarction. Circulation 2000;101:1919–24.[Abstract/Free Full Text]
  40. Welin C, Lappas G, Wilhelmsen L. Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med 2000;247:629–39.[CrossRef][Medline]
  41. Sullivan MD, LaCroix AZ, Russo J, Katon WJ. Self-efficacy and self-reported functional status in coronary heart disease: a six-month prospective study. Psychosom Med 1998;60:473–8.[Abstract/Free Full Text]
  42. Sullivan MD, LaCroix AZ, Russo JE, Walker EA. Depression and self-reported physical health in patients with coronary disease: mediating and moderating factors. Psychosom Med 2001;63:248–56.[Abstract/Free Full Text]
  43. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 1996;156:745–52.[Abstract]
  44. Lesperance F, Frasure-Smith N. The seduction of death. Psychosom Med 1999;61:18–20.[Free Full Text]
  45. Pollin I, Kanaan SB. Medical Crisis Counseling: Short-Term Therapy for Long-Term Illness. New York: WW Norton and Co; 1995.
  46. Snaith RP, Zigmond AS. Hospital Anxiety and Depression Scale (HADS). In: Rush AJ, Pincus HA, First MB, Blacker D, Endicott J, Keith SK, Phillips KA, Ryan ND, Smith GR, Tsuang MT, Widiger TA, Zarin DA, eds. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association; 2000.
  47. Spitzer RL, Williams BW, Kroenke K, Linzer M, deGruy FV, Hahn SR, Brody D. Primary Care Evaluation of Mental Disorders (PRIME-MD). In: Rush AJ, Pincus HA, First MB, Blacker D, Endicott J, Keith SK, Phillips KA, Ryan ND, Smith GR, Tsuang MT, Widiger TA, Zarin DA, eds. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association; 2000.
  48. Guy W. ECDEU Assessment Manual for Psychopharmacology–Revised. Department of Health, Education, and Welfare (DHEW) Pub. No. ADM 76–338. Rockville, MD: US Department of Health, Education, and Welfare, US Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Programs; 1976:218–22.
  49. Glassman AH, O’Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, McLvor M, Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701–9.[Abstract/Free Full Text]
  50. Guy W, Clinical Global Impressions (CGI) Scale. In: Rush AJ, Pincus HA, First MB, Blacker D, Endicott J, Keith SK, Phillips KA, Ryan ND, Smith GR, Tsuang MT, Widiger TA, Zarin DA, eds. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association; 2000.
  51. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS System for Mixed Models. Cary, NC: SAS Institute Inc; 1996.
  52. Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York: Oxford University Press; 2003.
  53. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:582–92.[CrossRef][Medline]
  54. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N. Enhancing recovery in coronary heart disease patients. I. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003;289:3106–16.[Abstract/Free Full Text]
  55. Hunkeler EM, Meresman JF, Hargreaves WA, Fireman B, Berman WH, Kirsch AJ, Groebe J, Hurt SW, Braden P, Getzell M, Feigenbaum PA, Peng T, Salzer M. Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Arch Fam Med 2000;9:700–8.[Abstract/Free Full Text]
  56. Simon GE, Von Korff M, Rutter C, Wagner E. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ 2000;320:550–4.[Abstract/Free Full Text]
  57. Eriksson I, Unden AL, Elofsson S. Self-rated health. Comparisons between three different measures. Results from a population study. Int J Epidemiol 2001;30:326–33.[Abstract/Free Full Text]
  58. Orfila F, Ferrer M, Lamarca R, Alonso J. Evolution of self-rated health status in the elderly: cross-sectional vs longitudinal estimates. J Clin Epidemiol 2000;53:563–70.[CrossRef][Medline]
  59. Kaplan G, Baron-Epel O. What lies behind the subjective evaluation of health status? Soc Sci Med 2003;56:1669–76.
  60. Kempen GI, Miedema I, van den Bos GA, Ormel J. Relationship of domain-specific measures of health to perceived overall health among older subjects. J Clin Epidemiol 1998;51:11–8.[CrossRef][Medline]
  61. Heidrich J, Liese AD, Lowel H, Keil U. Self-rated health and its relation to all-cause and cardiovascular mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984–1995. Ann Epidemiol 2002;12:338–45.[CrossRef][Medline]
  62. Cook TD, Campbell DT. Quasi-experimentation: design and analysis issues for field settings. Boston: Houghton Mifflin Co; 1979.



This article has been cited by other articles:


Home page
Eur Heart JHome page
W. Linden, M. J. Phillips, and J. Leclerc
Psychological treatment of cardiac patients: a meta-analysis
Eur. Heart J., December 2, 2007; 28(24): 2972 - 2984.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bambauer, K. Z.
Right arrow Articles by McLaughlin, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bambauer, K. Z.
Right arrow Articles by McLaughlin, T. J.
Related Collections
Right arrow Other Cardiovascular Medicine
Right arrow Therapeutic Interventions


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS